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Abstract
Postoperative pain is caused by neuronal damage that occurs during the surgical proce-
dure and the stimulation of the nociceptors. In postoperative period, total knee arthro-
plasty (TKA) is painful, and pain management is quite difficult. The main purpose of 
postoperative pain relief is to reduce the pain of the patient, to contribute to the healing 
process, to shorten the length of hospital stay, and to reduce hospital costs. Techniques 
such as intravenous analgesia, epidural analgesia, and peripheral nerve blocks are 
used to prevent postoperative pain. In addition, oral and parenteral analgesics, patient- 
controlled analgesia (PCA), nerve blocks, and periarticular injection methods are used 
as multimodal analgesia methods. Pain scales such as visual analogue scale (VAS), ver-
bal descriptive scale (VDS), and numerical rating scale (NRS) are used as the standard 
methods in the evaluation of pain of patients. Systemic opioids, nonsteroidal anti-inflam-
matory drugs, and local anesthetics are used for postoperative analgesia. Preemptive 
analgesia, defined as analgesia initiated prior to surgical incision, and multimodal anal-
gesia have been shown to reduce opioid consumption associated with high complication 
rates. Postoperative pain management should be planned considering the clinical charac-
teristics of the patient, experience of the anesthetist, and clinical facilities. Early postop-
erative analgesia reduces systemic complication rates and improves early rehabilitation, 
patient satisfaction, and quality of life.
Keywords: pain management, analgesia, preemptive analgesia, multimodal analgesia, 
regional analgesia techniques, drug therapy
1. Introduction
According to the definition made by the International Organization for Research on Aging 
(IASP), pain is a sensorial, emotional, unpleasant sensation about someone’s past experiences, 
whether they are connected to an organic gown or not, starting from anywhere in the body.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Classification of pain
1. Acute pain: it is a type of pain that starts suddenly, has a nociceptive nature, has tissue 
damage, shows a close relationship with the cause of the lesion in terms of location, time, 
and intensity, and gradually disappears as the healing progresses [1, 2]. The most common 
types of acute pain are posttraumatic, postoperative, and obstetric pain [3].
2. Superficial (cutaneous) pain: it is type of a pain that occurs against nociceptive stimuli that 
occur in skin, subcutaneous tissue, and mucous membranes.
3. Deep somatic pain: it is a pain that is usually caused by muscle, tendon, joint receptors or 
bones, which is blunt and cannot be localized.
4. Visceral pain: it is a pain originated from the deterioration of functions of their tissue (pa-
rietal pleura, pericardium, and peritoneum).
5. Chronic pain: it is defined as acute pain that begins as acute pain and lasts for 1–6 months [4].
3. Pain pathways
In order for a stimulus to be perceived as pain, it is necessary to go through four different 
physiological processes:
a. Transduction; at the end of the nerve is the stage where the stimulus is converted into 
electrical activity.
b. Transmission; it is the spread of electrical activity throughout the nervous system.
c. Modulation; changes in nociceptive transmission.
d. Perception; interaction with the individual’s psychology and subjective emotional 
experiences.
4. Postoperative pain in total knee arthroplasty
Postoperative pain is caused by neuronal damage that occurs during the surgical procedure 
and the stimulation of the nociceptors. In postoperative period, total knee arthroplasty (TKA) 
is painful and pain management is quite difficult. The main purpose of postoperative pain 
relief is to reduce the pain of the patient, to contribute to the healing process, to shorten the 
length of hospital stay, and to reduce hospital costs.
Techniques such as intravenous analgesia, epidural analgesia, and peripheral nerve blocks 
are used to prevent postoperative pain. In addition, oral and parenteral analgesics, patient- 
controlled analgesia, nerve blocks, and periarticular injection methods are used as multi-
modal analgesia method. Systemic opioids, nonsteroidal anti-inflammatory drugs, and local 
anesthetics are frequently used for postoperative analgesia.
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Pain scales such as visual analogue scale (VAS), verbal descriptive scale (VDS), numerical rat-
ing scale (NRS) are used as standard methods in the evaluation of pain of patients.
Total knee arthroplasty (TKA) is known to be a very painful orthopedic procedure [5]. For 
this reason, effective pain control is important to optimize the rehabilitation process in order 
to ensure patient satisfaction, hospital stay, and cost reduction [6]. However, the difficulty 
of postoperative pain management after TKA is to maintain adequate motor function with 
adequate analgesia. The patient is informed about the surgery to be performed before the 
operation, and a training program and the physical preparation are recommended. Patients 
undergoing preoperative exercise and training showed significant improvements in function, 
quadriceps strength, and duration of stay. After the surgical intervention is performed, the 
patient can continue the rehabilitation program to speed up the healing process in the home 
under the supervision of a physiotherapist. Rehabilitation therapy depends on many factors 
such as patient characteristics, prosthesis characteristics, and postoperative complications.
More than 1.1 million joint arthroplasty (TJA) are performed annually in the USA, and more 
than 700,000 of them are primary TKA [7, 8].
5. Pathophysiological changes caused by postoperative pain in the 
organism
Acute postoperative pain that is poorly treated is associated with both physiological and psy-
chological functions in the body [2, 9–11], which are as follows:
• Cardiovascular system: coronary ischemia, myocardial infarction
• Pulmonary system: hypoventilation, decreased vital capacity, pulmonary infection
• Gastrointestinal system: reduced motility, ileus, nausea, vomiting
• Renal system: increases in urinary retention and sphincter tone, oliguria
There are negative effects on the muscular system, on the coagulation system, on the wound 
healing, and on the immune system. Finally, poorly controlled pain after surgery may impair 
sleep and have negative psychological effects, such as demoralization and anxiety.
6. Postoperative pain treatment/management methods
1. Regional analgesia techniques and multimodal analgesia
2. Drug therapy
3. Nonpharmacological techniques
4. Preemptive analgesia
5. Patient education
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6.1. Regional analgesia techniques and multimodal analgesia
Despite improvements in pain management, approximately half of TKA (total knee arthro-
plasty) patients develop severe pain in the early postoperative period. Excessive tissue dam-
age and complex innervation in TKA make pain control difficult. Femoral nerve, sciatic nerve, 
and obturator nerve are involved in the innervation of the knee joint. In major surgeries, 
such as TKA, changes occur in the endocrine system and central, peripheral, and sympathetic 
nervous systems. If postoperative analgesia is not achieved adequately, systemic responses 
induced by the surgery increase and serious risks may occur to the patients.
Conventional methods such as parenteral opioids, epidural analgesia, and femur blocks have 
been widely used to remove the pain associated with TKA [12]. In addition, the fascia iliaca 
block has recently been used more frequently to reduce the pain associated with TKA [13]. 
Comparing general anesthesia with neuraxial anesthesia in the patients with TKA, the risk of 
perioperative complications was significantly reduced in patients undergoing neuraxial anes-
thesia [14]. In another study, the risk of short-term complications in patients with TKA was 
higher in patients receiving general anesthesia than in patients receiving neuraxial anesthesia 
[15]. Neuraxial anesthesia was associated with the reduction of major complications. A recent 
meta-analysis has shown that there is a significant decrease in the incidence of postoperative 
surgical site infection in neuraxial anesthesia when compared to general anesthesia and neur-
axial anesthesia in the patients with TKA and total hip arthroplasty (THA) [16]. The use of 
peripheral nerve block (PNB) also reduced the need for postsurgical critical care services [17].
Multimodal analgesia techniques are often used in the “fast-track” recovery protocols to 
improve pain relief. Mixture of local anesthetics and anti-inflammatory and opioid analgesics 
for periarticular infiltration has been used in the multimodal protocols. It can improve the pain 
score, reduce the total perioperative opioid consumption, enhance the early mobilization, and 
increase the patient satisfaction [18]. Several multimodal analgesics have been developed in 
clinical practice [19, 20] and paracetamol, nonsteroidal anti-inflammatory drugs (NSAIDs), opi-
oids, ketamine [21], alpha-2 adrenergic agonists [22], and corticosteroids have been used [23].
Periarticular drug injection is an attempt to apply a low-concentration, high-volume local 
anesthetic solution to the joint capsule and periarticular surrounding tissues to provide post-
operative analgesia [24]. When used as a part of a multimodal analgesic protocol in patients 
undergoing TKA, femoral nerve blockade has been shown to reduce narcotic consumption and 
improve postoperative pain scores [25]. However, periarticular infiltration is usually insuffi-
cient to provide adequate analgesia in the anterior direction of the knee [26]. Periarticular infil-
tration analgesic protocols that infiltrate anterior, posterior, and medial compartments of the 
knee are reported to only last between 6 and 12 h [27]. Prolonged motor blockade, quadriceps 
muscle weakness, difficulty ambulating, and postoperative falls limit the utility of femoral 
nerve block (FNB) in the “fast track” rehabilitation protocols [28, 29]. In a study, Fascia iliaca 
block effectively reduced the amount of morphine used after TKA in the first 24 h. This study 
shows that the fascia iliaca block provides the same level of analgesia with the use of less mor-
phine compared with the periarticular injection [30]. However, the fascia iliaca block requires 
as much as 40–50 mL of volume to achieve an effective result [31]. In another study, the anal-
gesic efficacy of the fascia iliaca block was compared to the femur nerve block in the guideline 
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of ultrasonography and no difference was found in VAS scores and opioid consumption [32]. 
The sciatic nerve block (SNB) is used in addition to FNB for complete analgesia after TKA. In 
a systematic review, SNB administered as a supplement to FNB has shown that it does not 
provide adequate analgesic activity [33]. Studies with larger patient groups showed a signifi-
cant reduction in postoperative opioid consumption, less opioid-induced adverse effects, and 
significantly lower resting and dynamic pain scores [34–38]. Adductor channel block was also 
studied. In the meta-analysis study performed, there was no significant difference in pain con-
trol and morphine consumption between the adductor canal bloc (ACB) and the femoral nerve 
block (FNB) group. However, it was observed that ACB provided faster postoperative mobili-
zation ability without reduction of analgesia in patients undergoing TKA [39]. Another study 
conducted after TKA to compare the efficacy of single-shot adductor canal block (SACB) and 
postoperative continuous adductor canal block (CACB) placement and showed that CACB 
was superior to SACB for analgesia control but ambulation ability, success rate, early func-
tional recovery, and treatment-related side effects were similar [40]. Different studies have 
shown that ACB and FNB have similar motor function recovery, strength ratings, and quadri-
ceps muscle strength at postoperative 24 and 48 h in TKA patients [41, 42].
6.2. Drug therapy
TKA operation is one of the most painful orthopedic procedures [43]. For this reason, it is 
difficult to provide adequate analgesia with a single drug or method. Multimodal analgesia 
methods will be more appropriate to reduce side effects and provide pain control. Multimodal 
analgesia is defined as providing more effective pain control by the combined use of various 
analgesic drugs and techniques that may have additive or synergistic effects targeting differ-
ent pain mechanisms in the peripheral and/or central nervous system [44].
In multimodal pain management, patient education, preemptive oral medications, regional 
anesthesia methods, peripheral nerve blocks, local infiltrations, and postoperative rehabilita-
tion are included. Most of the side effects seen in analgesia treatment are due to the parenteral 
opioid. One of the main goals of multimodal analgesia is to reduce the need for opioids.
6.2.1. Nonsteroidal anti-inflammatory drugs
Tissue inflammation in TKA surgery triggers the production of PGs that play a role in acute 
postoperative pain. NSAIDs reduce central sensitization by inhibiting central and peripheral 
prostaglandin synthesis. It may be effective for 2 weeks when inflammation continues in the 
postoperative period. Ketorolac is a nonselective COX inhibitor and has oral, parenteral, oph-
thalmic, and nasal forms. It is used in moderate and severe postoperative pain management 
after major surgeries [45]. It reduces opioid consumption when used as a part of multimodal 
pain management [46]. The use of NSAIDs can cause gastritis or peptic ulcer formation and 
impair platelet aggregation, renal function, and wound healing. For this reason, there are con-
cerns about their use in the perioperative period. Preemptive use of selective COX-2 (cyclo-
oxygenase) inhibitors (celecoxib and rofecoxib) has been shown to reduce postoperative pain 
scores in the knee surgeries [47]. The use of selective COX2 inhibitors in TKA surgeries has been 
shown to reduce opioid consumption, provide early onset of physical rehabilitation, and reduce 
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nausea and vomiting [48]. Similarly, diclofenac or ketorolac administered in a single dose in 
joint arthroplasty patients reduced morphine consumption by 29% compared to placebo [49].
6.2.2. Paracetamol
It is nonopioidand and non-NSAID analgesic. It inhibits prostaglandin synthesis in the CNS 
and plays a role in preventing central sensitization. There is a minimal effect on peripheral 
PG synthesis. Unlike NSAIDs, the anti-inflammatory effect is poor, and there are no nega-
tive effects on platelet function and gastric mucosa. It has been shown that 1 g intravenous 
paracetamol provides rapid and effective analgesia in major orthopedic surgeons [50]. 
Paracetamol can be administered 1 g/day four times. When combined with paracetamol and 
NSAIDs, better analgesia is achieved when both drugs are used alone [51].
6.2.3. Glucocorticoids
Glucocorticoids have strong anti-inflammatory effects. Corticosteroids are thought to be an 
important component because of their local anti-inflammatory effects and their ability to 
reduce the local stress response in the operation [52]. There have been many studies on cor-
ticosteroids, and conflicting evidence has been obtained about their benefits [53–58]. Some 
studies have shown that postoperative pain is improved with corticosteroids [53–56] but 
other studies do not benefit [57, 58]. In another study, postoperative pain level was lower in 
the corticosteroid group than that in the noncorticosteroid group in first 24 h [59]. In a meta-
analysis, dexamethasone, a long-acting glucocorticoid, has been shown to reduce postopera-
tive pain and opioid consumption [60]. In one study, it was shown that preoperative single 
dose iv 40 mg dexamethasone reduced dynamic pain scores [61]. Another study showed that 
dexamethasone administered as a part of multimodal analgesia in 269 patients undergoing 
TKA reduced postoperative pain and bulimia and did not increase wound complications [62]. 
In contrast to these studies, patients with a periarticular injection with high- and low-dose 
corticosteroids were compared and found no improvement in postoperative pain level [58]. 
Surgical techniques such as the surgical approach and the use of pneumatic turniken may be 
effective on early postoperative pain [63, 64]. One of the most commonly used corticosteroids 
for periarticular injection is methylprednisolone [52, 57, 65–67].
6.2.4. Opioids
Opioids have been used to provide analgesia and relieve anxiety for centuries. Opioid recep-
tors are found in many regions of the CNS. These receptors are located in the central nervous 
system, cerebral cortex, hypothalamus, thalamus, midbrain extrapyramidal area, substantia 
gelatinosa, and sympathetic preganglionic nerves. Places with the highest concentration of 
these receptors are structures and pathways associated with pain [68].
The first opioid receptors were found in 1973. Later, endogenous opioids were found. There 
are four types of receptors. These include mu (μ), kappa (k), sigma (s), and delta (d) receptors. 
Opioids show their effect by linking their receptors.
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1. Mu (μ) receptors: specific morphine agonist. It is stimulated by morphine and is responsi-
ble for supraspinal analgesia.
2. Kappa (k) receptors: they are responsible for spinal analgesia and sedation.
3. Sigma (s) receptors: responsible for dysphoria and hallucinations.
4. Delta (d) receptors: beta-endorphin and encephalin are specific agonists. It is influential on 
motor integration and urine function.
Classification of opioids:
1. Natural opioids: phenanthrene derivatives: codeine, morphine, and thebaine. Benzyliso-
quinoline derivatives: papaverine.
2. Synthetic opioids: phenylpiperidine derivatives (fentanyl, sufentanil, and meperidine), 
benzomorphan derivatives (pentazocine and phenazocine), diphenylpropyl or methadone 
derivatives (methadone and d-propoxyphene), and morphinan derivatives (levorphanol).
3. Semisynthetic opioids: dihydromorphone/morphinone, heroin, and thebaine derivatives 
(etorphine).
Morphine contains the basic properties of the majority of the structures of the opioids. The 
effects of morphine in the central nervous system, analgesia, euphoria and sedation. The most 
important effect of morphine on the central nervous system therapeutically is analgesia.
Analgesia provided by systemic opioids often accompanies side effects such as sedation, nau-
sea, pruritus, urinary retention, and constipation. However, they continue to be an important 
part of severe postoperative pain management [69]. They can be used intramuscularly, intra-
venously, orally, rectally, sublingually, subcutaneously, epidurally, or intrathecally. If patients 
are able to use the oral route, oral administration is recommended. Side effects of oral opioids 
are less frequent and are mostly related to the gastrointestinal system. Intravenous patient-
controlled analgesia (PCA) should be preferred if the parenteral route is used. Intravenous opi-
oid PCA is recommended for bolus application with appropriate lock interval without basal 
infusion. In the postoperative period, it is usually administered via intravenous PCA for the 
first 24–48 h and then is used as oral agents [44]. Oral opioids have immediate release and 
controlled release forms [70]. Rapid-release patients are effective in the treatment of moderate 
and severe postoperative pain, but are impractical because they need to be reapplied every 4 h. 
Since postoperative pain is continuous at the beginning, analgesics should be used regularly 
especially in the first 24 h. Long-acting oxymorphone and oxycodone have been shown to be 
effective in postoperative analgesia in TKAs [71, 72]. Especially morphine and fentanyl are fre-
quently used for postoperative analgesia in ТKА cases. The application of intrathecal morphine 
and fentanyl is very effective in postoperative pain control. In a study conducted, 0.2 mg and 
0.3 mg intrathecal morphine administration was shown to be effective for postoperative anal-
gesia [73]. Other studies have been done to support this study. The use of 0.5 mg intrathecal 
morphine has been shown to be more reliable and more effective than injections of 0.2 mg [74]. 
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Intrathecal morphine is less hydrophobic than other opioids, has a longer duration in the 
cerebrospinal fluid, and provides very good postoperative analgesia [75]. On the other hand, 
another study reported that morphine should not be used even in small doses due to these side 
effects [76]. Opioids are known to produce more effective and long-lasting anesthesia when 
used with local anesthetics. Opioids are known to produce more effective and long-lasting 
anesthesia when used with local anesthetics [77, 78]. In a study of TKA cases, we compared the 
use of intrathecal morphine and fentanyl for postoperative analgesia and found that fentanyl 
provided more effective postoperative analgesia [79]. Long-acting opioids (LAO) are often 
used for malignant, nonmalignant, and different pain treatments. A lot of work about LAO 
(oxycodone, morphine) has been done in this regard. In a study on LAO, there was a decrease 
in pain while there was an increase in vomiting and sedation [80]. After the use of LAO (oxyco-
done), the rehabilitation of patients was found to be better in TKA cases [81]. In the studies per-
formed, intravenous PCA and oxycodone were compared and there was no difference in pain 
[82], and no difference in pain after LAO (oxycodone) used after total joint arthroplasty [83].
6.2.5. Gabapentinoids (gabapentin and pregabalin)
Gabapentin has been shown to be effective in the treatment of herpetic neuralgia, neuropathic 
pain [84], and diabetic neuropathy [85]. These anticonvulsant drugs, which have been used 
for a long time in the management of chronic pain, have started to be used in acute postop-
erative analgesia in recent years. They may cause side effects such as sedation and dizziness. 
It has been shown that administration of pregabalin (300 mg preoperatively and 150–50 mg 
twice daily for the first 14 days postoperatively) reduces the incidence of opioid consumption 
and neuropathic pain development after TKA [86]. We also have studies showing that postop-
erative analgesia is reduced after the application of preoperative gabapentin and pregabalin 
in lower extremity surgeons [87, 88]. Another study has shown that gabapentin effectively 
reduces postoperative narcotics consumption and pruritus incidence [89]. In another meta-
analysis trial, the use of pregabalin shows that it could improve pain control at 24 and 48 h 
with rest, reduce morphine consumption, and improve knee flexion level, as well as reduce 
nausea, vomiting, and pruritic event rate. However, pregabalin increased the incident rate of 
dizziness after total knee arthroplasty (TKA) and total hip arthroplasty (THA) but could not 
improve the pain control at 72 h with rest [90].
6.2.6. Ketamine
Ketamine is used by anesthetists for sedation and general anesthesia. With the detection of 
the N-methyl-d-aspartate receptor’s role in nociceptive pain transmission and central sensi-
tization, ketamine has begun to be used as a potential antihyperalgesic agent. Subanesthetic 
low doses of ketamine provide significant analgesic efficacy without psychomimetic side 
effects [45]. Low-dose ketamine has no adverse effects on respiratory and cardiovascular sys-
tem and does not cause nausea-vomiting, urinary retention and constipation or postopera-
tive ileus. In patients receiving TKA, low-dose ketamine infusion has been shown to reduce 
morphine consumption postoperatively (3 μg/kg per minute intraoperatively and 1.5 μg/kg 
per minute for 48 h) [91].
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6.3. Nonpharmacological techniques
There have been many studies on surgical techniques and equipment, but most have had 
no or limited effect on postoperative analgesia. These studies focused on drains, surgical 
approaches, tourniquet use, prosthetic types, and reshaping of the patellar surface. A compar-
ison of cooling and compression techniques with the control group showed that postoperative 
pain and morphine consumption were reduced [92]. The efficacy of TENS administration in 
postoperative analgesia after TDP was not demonstrated [93]. The results of cryotherapy are 
contradictory. The potential benefits of cryotherapy in a meta-analysis are not clinically sig-
nificant [94]. Routine use is therefore not recommended.
6.4. Preemptive analgesia
Analgesics are administered before painful stimulation to prevent peripheral and central 
sensitization. Preemptive analgesia inhibits peripheral sensitization and central sensitiza-
tion. It should also prevent inflammatory and neuropathic pain types [95]. Local anesthetic 
infiltration, regional anesthesia methods, and drugs (NMDA receptor antagonists, opioids, 
COX-2 inhibitors, nonsteroidal anti-inflammatory drugs (NSAID), and local anesthetics) 
can be used for preemptive analgesia. According to a study, preemptive analgesia is sta-
tistically significant, although not clinically significant [96]. When preemptive analgesia is 
administered, it should be considered as a method of pathological pain as well as physi-
ological conventional perioperative analgesia [97]. Preemptive analgesia is an effective 
method in clinical practice for the approach to postoperative pain involving incisional and 
inflammatory injury [98].
Drugs used in preemptive analgesia:
1. Local anesthetics
2. Nonsteroidal anti-inflammatory drugs (NSAIDs)
3. COX-2 inhibitors
4. Opioids
5. NMDA receptor antagonists
6.5. Patient education
There are two major components of pain perception: the sensory discriminative component 
and the motivational affective component [99]. Emotional component is targeted with patient 
education. Patients and their relatives are informed, and their anxiety is reduced by elimi-
nating their fears about the unknown; the realistic goals are identified, and a relationship is 
established with patients and their relatives; the patient satisfaction increases, and the pain 
scores decrease [100].
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7. Conclusion
In TKA, many methods are proposed and used for postoperative pain management. There are 
many factors that affect postoperative pain management. The age of the patient, the experi-
ence of the surgeon, the technical conditions, and the method used are some of these. Taking 
all these factors and literature into consideration, the use of multimodal analgesia techniques 
is recommended.
Systemic medications for postoperative analgesia after TKA:
1. Paracetamol
2. NSAIDs
a. Celecoxib
b. Ibuprofen
c. Naproxen
d. Ketorolac
3. Ketamine
4. Gabapentinoids
a. Gabapentin
b. Pregabalin
5. Glucocorticoids
6. Opioids
a. Morphine
b. Fentanyl
c. Hydromorphone
d. Hydrocodone
e. Tramadol
f. Extended-release oxycodone
g. Extended-release morphine
8. Key rules in knee rehabilitation
1. Bone-bond stability is a prerequisite for optimal knee function recovery [101, 102].
2. Postsurgery rehabilitation program should be started early.
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3. During the rehabilitation program, unbalanced and full weight should not be allowed un-
til a normal range of motion and walking pattern is achieved.
4. The development of reflex inhibition in the extensor or flexor mechanisms should be rec-
ognized early and must be struggled in the appropriate modalities.
5. The operated and unoperated extremities should be strengthened together.
6. For the success of the rehabilitation program, orthopedic surgeon, physical medicine and 
rehabilitation specialist, physiotherapist, occupational therapist, nurse, and the social team 
of service specialists need to communicate well.
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